Cardiopoietic stem cells derived from bone marrow pass phase 2 heart-failure test TheHeart.Org Aalst, Belgium - Bone-marrow-derived autologous cardiopoietic stem cells injected into the hibernating myocardium of patients with heart failure improves left ventricular ejection fraction as well as six-minute-walk test and quality-of-life scores ... |
